Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
21.58
-0.91 (-4.05%)
May 13, 2025, 4:00 PM - Market closed
Vera Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 55.09 | 92.65 | 45.68 | 43.46 | 79.67 | 53.65 | Upgrade
|
| Short-Term Investments | 534.74 | 548.21 | 115.04 | 71.19 | - | 0.09 | Upgrade
|
| Cash & Short-Term Investments | 589.83 | 640.85 | 160.72 | 114.65 | 79.67 | 53.74 | Upgrade
|
| Cash Growth | 46.12% | 298.75% | 40.18% | 43.90% | 48.26% | 1564.29% | Upgrade
|
| Other Receivables | 3.59 | 3.77 | 0.51 | - | - | 0.05 | Upgrade
|
| Receivables | 3.59 | 3.77 | 0.51 | - | - | 0.05 | Upgrade
|
| Prepaid Expenses | 10.87 | 5.68 | 8.56 | 10.33 | 2.38 | 0.03 | Upgrade
|
| Restricted Cash | - | - | - | - | - | 0.05 | Upgrade
|
| Other Current Assets | 1.79 | 0.91 | 2.24 | 0.72 | 0.48 | 0.39 | Upgrade
|
| Total Current Assets | 606.08 | 651.22 | 172.02 | 125.7 | 82.54 | 54.26 | Upgrade
|
| Property, Plant & Equipment | 3.98 | 4.33 | 3.04 | 5.22 | - | - | Upgrade
|
| Long-Term Investments | - | - | - | 0.06 | 0.87 | - | Upgrade
|
| Other Long-Term Assets | 0.11 | 0.13 | 0.48 | 0.46 | 0.34 | 0.29 | Upgrade
|
| Total Assets | 610.17 | 655.68 | 175.55 | 131.44 | 83.75 | 54.55 | Upgrade
|
| Accounts Payable | 9.26 | 7.67 | 11.12 | 11.99 | 1.39 | 0.91 | Upgrade
|
| Accrued Expenses | 11.44 | 16.22 | 8.75 | 10.96 | 5.93 | 0.54 | Upgrade
|
| Current Portion of Leases | 1.19 | 1.48 | 2.44 | 2.65 | - | - | Upgrade
|
| Other Current Liabilities | - | - | - | - | 0.38 | 0.96 | Upgrade
|
| Total Current Liabilities | 21.89 | 25.37 | 22.3 | 25.6 | 7.69 | 2.41 | Upgrade
|
| Long-Term Debt | 50.91 | 50.69 | 49.88 | 24.81 | 4.92 | - | Upgrade
|
| Long-Term Leases | 2.37 | 2.47 | 1.4 | 3.83 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.29 | 0.29 | 1.54 | 1.92 | Upgrade
|
| Total Liabilities | 75.17 | 78.53 | 73.86 | 54.53 | 14.16 | 4.33 | Upgrade
|
| Common Stock | 0.06 | 0.06 | 0.04 | 0.03 | 0.02 | - | Upgrade
|
| Additional Paid-In Capital | 1,047 | 1,038 | 410.49 | 290.22 | 193.63 | 2.1 | Upgrade
|
| Retained Earnings | -512.94 | -461.25 | -309.1 | -213.11 | -124.06 | -91.45 | Upgrade
|
| Comprehensive Income & Other | 0.65 | 0.39 | 0.25 | -0.22 | - | - | Upgrade
|
| Total Common Equity | 535 | 577.16 | 101.69 | 76.91 | 69.59 | -89.35 | Upgrade
|
| Shareholders' Equity | 535 | 577.16 | 101.69 | 76.91 | 69.59 | 50.23 | Upgrade
|
| Total Liabilities & Equity | 610.17 | 655.68 | 175.55 | 131.44 | 83.75 | 54.55 | Upgrade
|
| Total Debt | 54.47 | 54.64 | 53.71 | 31.29 | 4.92 | - | Upgrade
|
| Net Cash (Debt) | 535.37 | 586.21 | 107.01 | 83.37 | 74.75 | 53.74 | Upgrade
|
| Net Cash Growth | 52.79% | 447.82% | 28.36% | 11.53% | 39.10% | 1635.23% | Upgrade
|
| Net Cash Per Share | 9.15 | 10.60 | 2.51 | 3.14 | 5.56 | 167.96 | Upgrade
|
| Filing Date Shares Outstanding | 63.77 | 63.75 | 54.45 | 44.26 | 27.05 | 0.36 | Upgrade
|
| Total Common Shares Outstanding | 63.77 | 63.56 | 44.45 | 27.8 | 21.28 | 0.36 | Upgrade
|
| Working Capital | 584.18 | 625.85 | 149.72 | 100.1 | 74.85 | 51.86 | Upgrade
|
| Book Value Per Share | 8.39 | 9.08 | 2.29 | 2.77 | 3.27 | -251.47 | Upgrade
|
| Tangible Book Value | 535 | 577.16 | 101.69 | 76.91 | 69.59 | -89.35 | Upgrade
|
| Tangible Book Value Per Share | 8.39 | 9.08 | 2.29 | 2.77 | 3.27 | -251.47 | Upgrade
|
Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.